Shulin Wu

Title: Shulin Wu: Innovator in Chemical Processes

Introduction

Shulin Wu is a notable inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of chemistry, particularly in the synthesis of complex organic compounds. With a total of 2 patents, his work has implications in various applications, including pharmaceuticals.

Latest Patents

Wu's latest patents include the synthesis of 1,2,5-tri-o-benzoyl-3-dibenzylamino-3-deoxyribose as an intermediate for producing 3'-amino-3′-deoxyadenosine and 3′-amino-3′-deoxyguanosine and the protected derivatives thereof. This invention relates to improved processes for preparing intermediates of a cyclic dinucleotide, which is useful as a STING agonist. Another significant patent involves a process for producing N-acylated-4-aryl beta-amino acid derivatives, which focuses on creating an enantiomerically enriched compound through hydrogenation in the presence of a transition metal catalyst.

Career Highlights

Throughout his career, Shulin Wu has worked with prominent companies such as Bristol-Myers Squibb Company and Chiral Quest, Inc. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects in the pharmaceutical and chemical industries.

Collaborations

Wu has collaborated with notable coworkers, including Changxia Yuan and Michael Anthony Schmidt. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in their respective fields.

Conclusion

Shulin Wu's contributions to chemical processes and his innovative patents highlight his role as a significant inventor in the industry. His work continues to influence advancements in pharmaceuticals and organic chemistry.